Hyoxyson

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hyoxyson

Property Description
Active Ingredients Hydrocortisone, Oxytetracycline Hydrochlorid
Form Topical Preparation (Ointment or Suspension)
Pharmacological Class Corticosteroid and Tetracycline Antibiotic Combination
Common Use Managing localized inflammation and associated bacterial involvement
Origin Semi-synthetic (derived from natural compounds)

Classification and Composition: What Kind of Drug is Hyoxyson?

Hyoxyson is a prescription-only combination product classified within the pharmacological group of a topical corticosteroid with an anti-infective agent. This medicine is defined by its two principal active ingredients: the glucocorticoid Hydrocortisone and the broad-spectrum antibiotic Oxytetracycline Hydrochlorid. The formulation integrates a compound from the corticosteroid pharmacological class with an agent from the tetracycline antibiotic class, combining their effects into a single preparation for topical administration. Oxytetracycline itself is a derivative isolated from the actinomycete Streptomyces rimosus, highlighting its semi-synthetic origin. This specific combination is widely recognized in dermatological practice for its dual therapeutic capacity in targeted local applications.

Dual-Action Formulation: Why Does Hyoxyson Combine Ingredients?

The dual-action structure of Hyoxyson’s formulation provides a simultaneous approach to managing both inflammation and potential bacterial involvement at the site of application. This fundamental general purpose involves both components acting concurrently. Hydrocortisone supplies crucial anti-inflammatory activity, rapidly mitigating the discomforting signs of irritation, such as swelling and itching. Concurrently, the Oxytetracycline Hydrochlorid component provides broad-spectrum antibacterial activity by exerting a bacteriostatic effect, which targets the inhibition of protein synthesis necessary for bacterial growth.

These fixed-dose preparations are designed to provide simultaneous anti-inflammatory and anti-infective action. Using one product to address both issues can simplify the management of irritated or infected areas, a common scenario in localized skin conditions. This synergistic composition is designed to address steroid-responsive inflammatory conditions where microbial involvement is present or anticipated, offering a single, targeted means of relief.

Regulatory References

  1. Terra-Cortril (Oxytetracycline/Hydrocortisone) SmPC

What side effects are possible with Hyoxyson?

Possible Side Effects and Safety Information

Hyoxyson is associated with a safety profile reflecting its systemic effects, primarily immunosuppression and metabolic/endocrine disturbances, as documented in regulatory labeling.

Adverse Reaction Scope

The most serious documented risk is an increased susceptibility to infection (e.g., viral, bacterial, fungal), which can be severe, disseminated, or fatal, with the risk rising alongside increasing dosage. Other serious and clinically significant adverse reactions include posterior subcapsular cataracts, glaucoma (with possible optic nerve damage), peptic ulceration (with potential for perforation or hemorrhage), Strongyloides hyperinfection, and Kaposi’s sarcoma.

Commonly observed side effects involve several system-organ classes, including:

  • Fluid and Electrolyte (e.g., sodium retention, hypokalemia)
  • Musculoskeletal (e.g., muscle weakness, osteoporosis, tendon rupture)
  • Neurological/Psychic (e.g., mood swings, insomnia, severe depression, convulsions)
  • Endocrine (e.g., HPA axis suppression, Cushingoid state)

Safety Restrictions and Population Considerations

Safety-related limitations stipulate that Hyoxyson is contraindicated in patients with systemic fungal infections unless it is required to manage drug reactions. Use is also advised against in cases of cerebral malaria. Abrupt discontinuation after prolonged use may lead to adrenal insufficiency and is generally not recommended.

Population-specific safety notes highlight the need for careful observation of growth and development in pediatric patients due to the risk of bone growth inhibition. Pregnant individuals are advised to weigh potential benefits against the risks to the fetus. Patients with pre-existing conditions like ocular herpes simplex, congestive heart failure, hypertension, or active peptic ulcers require cautious use.

Overdose and Emergency Response

Overdose is a medical emergency that requires immediate professional attention. A drug overdose occurs when a toxic amount of a substance is taken, either intentionally or accidentally, potentially leading to severe, life-threatening effects.

Overdose Presentations

Symptoms of a significant overdose depend on the substance's mechanism of action but often involve profound central nervous system and cardiovascular changes. Common manifestations may include extreme drowsiness, confusion, slow or shallow breathing, an abnormally slow or erratic pulse, gurgling or choking sounds, and a limp body. Discoloration of the lips, nails, or skin to blue or ashen tones indicates dangerously low oxygen levels, which is a critical sign.

When to Seek Help

Immediate medical help is required if you suspect a Hyoxyson overdose, or if any person exhibits sudden and profound changes in consciousness, breathing, or heart rate. Do not wait for all symptoms to appear. Call your local emergency number (e.g., 911 or 112) immediately.

While waiting for emergency services, if the person is unresponsive but breathing, roll them into the recovery position to prevent choking. Do not attempt to induce vomiting or give the person food or drink. Follow the instructions of the emergency dispatcher until professional medical help arrives. The prompt administration of supportive care is essential for a positive outcome.

Therapeutic Uses of Hyoxyson

What Hyoxyson Treats: Main Uses and Benefits

Hyoxyson is primarily used in the management of steroid-responsive inflammatory skin conditions where the symptoms are complicated by a secondary bacterial infection. Such disorders include exudative and secondarily infected eczema (including atopic eczema), allergic dermatitis, and secondarily infected insect bite reactions. The medication is generally applied in situations involving certain distressing symptoms, where clusters of discomfort, such as swelling, redness, intense itching, and surface weeping, appear together and interfere with daily functioning.

This dual therapeutic approach is relevant when supportive symptom management is appropriate, as it helps address both the inflammatory and the microbial components concurrently. This dual strategy is intended to support a more manageable experience of day-to-day functioning and comfort by easing the impact of the most distressing manifestations. It is generally used across conditions presenting with acute episodes and helps maintain a sense of stability when symptoms are more noticeable.


Quick Fact: Relief for Combined Symptoms

The medicine is considered relevant for easing skin discomfort in scenarios where inflammation (from dermatitis) and microbial presence (from secondary infection) occur together.

Eligibility and Restrictions for Use

Contraindications and Prohibited Populations

This section defines the official population eligibility for Hyoxyson as documented in regulatory sources, clarifying who is officially prohibited from using the medicine and who may be eligible.

The medicine is contraindicated and must not be used by several key populations. Absolute prohibitions apply to pregnant patients and nursing mothers. The product is also contraindicated in infants and small children due to the theoretical risk of permanent tooth discoloration associated with the tetracycline component. Furthermore, patients with a known hypersensitivity to any component of the preparation are excluded.

Eligibility Based on Condition and Age

Eligibility is strictly defined by the type of infection. Hyoxyson is contraindicated for use in patients with primary bacterial infections, or any viral (e.g., herpes simplex, varicella) or primary fungal diseases of the skin. Its use is not recommended in children.

For adults and the elderly, use is generally permitted. Regulatory documents note that no special precautions are required based on a patient’s renal impairment or hepatic impairment status. Patients are restricted from using the product under occlusive dressings or for prolonged periods due to the potential for increased systemic absorption.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Hyoxyson, a topical combination product containing Hydrocortisone and Oxytetracycline, indicates that no interactions with other co-administered medicinal products have been established for its intended topical use. This finding means that external drug-drug, drug-food, or drug-substance interaction patterns are not formally documented in the current regulatory labeling. The overall interaction structure is defined by this absence of established external risks and focuses instead on constraints tied to the method of administration.

Official Interaction Profile Summary

Interaction Scope Regulatory Statement
Documented External Interactions None established with other medicinal products.
Specific Interacting Agents None explicitly listed in official labeling.
Timing or Separation Rules None documented; no mandatory time separation rules are specified for co-administered products.
Population-Specific Notes No special precautions are required regarding interactions in populations with renal or hepatic impairment.

Exposure-Context Constraints

The only formally documented caution relates to the conditions of application that can modify the drug's systemic exposure. Regulatory labels specify that applying the product to extensive areas of skin or utilizing an occlusive technique (such as a bandage) may result in increased systemic absorption of the Hydrocortisone (corticosteroid) component. This is a condition-based constraint that affects drug exposure and must be considered during application.

Mechanism of Action

Modulation of Inflammatory Cascades through Genomic Mechanisms

The corticosteroid component, Hydrocortisone, acts as an agonist for the cytoplasmic Glucocorticoid Receptor (GR). This drug-receptor complex translocates to the nucleus to engage in transrepression, which prevents the transcription of genes responsible for creating key inflammatory mediators like prostaglandins and leukotrienes. This mechanism modifies molecular signaling sequences that influence systemic physiological outcomes, resulting in reduced tissue fluid extravasation and decreased immune cell chemotaxis at the application site.


Bacteriostatic Mechanism via Ribosomal Inhibition

The anti-infective component, Oxytetracycline, functions as an inhibitor by targeting the bacterial 30S ribosomal subunit. By binding to this structure, the drug physically blocks the entry of aminoacyl-tRNA, thereby arresting the bacterial cell's ability to synthesize essential proteins. This mechanistic domain supports the interference with the microbial protein synthesis pathway, resulting in the functional arrest of bacterial proliferation (bacteriostasis).


Complementary Mechanisms Targeting Host Response and Microbial Factors

The formulation engages mechanisms that influence two distinct processes simultaneously: the host’s amplified inflammatory response and the localized microbial proliferation. This concurrent activity addresses both the suppression of inflammatory mediators and the inhibition of microbial proliferation, influencing two distinct pathological processes simultaneously.

Dosage and Administration Information

How to Use Hyoxyson: Administration Guidelines

Hyoxyson, a combination product containing a corticosteroid and an antibiotic, is administered according to established protocols. The use is site-specific, depending on the preparation's form, and follows specific time limits and application steps.


Administration Scope

The preparation is approved for Topical use on the skin via the Ointment form, and for Ocular and Auricular instillation via the Suspension form, establishing distinct usage pathways.

Usage Parameter Instructions
Dosing Schedule Apply a thin layer of the ointment, or instill one to four drops of the suspension (varies by site).
Frequency The ointment is typically applied two to four times daily; the suspension is often administered three times daily.
Preparation Ointment application must be preceded by thorough cleansing of the skin area; suspensions must be shaken well before use.
Duration Limit The topical ointment should not be continued for more than seven days if clinical improvement is absent, emphasizing a short-term course.

Population and Procedural Conditions

There are specific considerations for different populations and administration contexts. The topical ointment is not recommended for use in infants and small children. For adults, the ointment is strictly for external use only and must not be used on the eyes. The protocol for use dictates that treatment should be continued to complete the full prescribed course, and that occlusive dressings should not be used over the treated area unless specifically instructed by a healthcare professional.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Hyoxyson

The research available for this combination medicine was studied for specific clinical contexts, primarily focusing on its two active components. The body of evidence includes findings from controlled trials and larger reviews, which help contextualize how the medicine was observed under study conditions.

Evidence for Use in Secondarily Infected Eczema and Dermatitis

Research has examined this medicine for conditions characterized by fluctuating or episodic manifestations, such as eczema and dermatitis, where the skin may develop an associated bacterial presence. Studies primarily involved adults and children over the age of six. Researchers focused on outcomes related to physical discomfort, monitoring changes in visible symptoms like redness and swelling, alongside patient-reported outcomes describing perceived discomfort, such as itching.

Systematic reviews and meta-analyses reported that, across various trials, findings describe patterns observed in the studies related to outcomes linked to inflammatory or irritative states that were recorded over the short term. However, evidence suggests that establishing an additional measured difference over topical steroid used alone for mild-to-moderate infected eczema was observed in some studies but not consistently across all available data.

Comparison of Combination Therapy Studies

Research examined whether the dual formulation resulted in patterns of outcomes linked to inflammatory or irritative states that differed from the single ingredient. These reviews often noted that certainty remains low due to how the available evidence was observed in and the variability across different trials.

Long-Term Research and Study Duration

In clinical trials for secondarily infected eczema, the follow-up durations were limited, typically focusing on the first few weeks of use. Research so far indicates that the available evidence provides insight into short-term changes only. Regarding the duration and stability of any observed patterns, long-term effects are not fully established.

Understanding Evidence Quality and Research Gaps

The evidence base for this combination is often characterized by a low certainty level. Key research limitation frames include that sample sizes were modest in many of the individual trials. A primary research limitation is that the long-term effects are not fully established regarding the use of topical antibiotics and their potential association with the development of antimicrobial resistance over time.

Frequently Asked Questions (FAQ)

Common questions about Hyoxyson (FAQ)


Q: Is Hyoxyson the same kind of medicine as [similar generic name]?

A: According to regulatory classification, Hyoxyson is defined as a combination product. It contains two active ingredients: a corticosteroid (Hydrocortisone) and an antibiotic (Oxytetracycline).

Therefore, single-ingredient medicines or products containing a different combination of components would not be considered the same kind of preparation as Hyoxyson.


Q: What happens if I miss taking a dose of Hyoxyson?

A: Regulatory guidance for some formulations advises that if a dose is missed, it may be used as soon as possible, or missed if it is close to the next scheduled time.

However, the full prescribed course of treatment should generally still be completed as directed by a healthcare professional.


Q: Is Hyoxyson considered a controlled substance?

A: Regulatory information indicates that the active ingredients in Hyoxyson, Hydrocortisone and Oxytetracycline, are not typically classified as controlled substances under national drug acts.

This classification means the medicine is not subject to the same strict dispensing and prescribing regulations as opioid pain relievers or other highly addictive substances.


Q: Can Hyoxyson cause difficulty sleeping or insomnia?

A: Insomnia, or difficulty sleeping, is listed in official documents as a possible adverse reaction associated with the corticosteroid component of Hyoxyson.

This effect is typically related to the systemic effects of the drug, which may occur from absorption after topical use, especially when used extensively.


Q: Is it common to feel tired when first starting Hyoxyson?

A: Official documentation does not specifically list 'tiredness' or fatigue as a common side effect of the topical preparation.

Official documentation does not typically list 'tiredness' as a common side effect, though related systemic effects like muscle weakness are noted as potential adverse reactions associated with the corticosteroid component.


Q: Does Hyoxyson interact with popular supplements like multivitamins or herbal remedies?

A: Official regulatory labels state that no interactions with other co-administered medicinal products have been formally established for the intended topical use of Hyoxyson.

This absence of established risk applies to supplements and herbal remedies as well.


Q: Are there studies that look at long-term use of Hyoxyson?

A: Regulatory overviews note that clinical trials supporting the medicine’s use had limited follow-up durations, focusing primarily on short-term results (the first few weeks).

As such, the official evidence base indicates that the long-term effects and stability of any observed outcomes are not fully established.


Q: Can elderly patients use Hyoxyson safely?

A: Official labeling for the topical ointment explicitly states that no special precautions are noted or required for the use of the product in the elderly population.

This classification is based on the safety profile established for the intended topical use.


Q: How is Hyoxyson different from older medicines used for the same purpose?

A: Hyoxyson is characterized by its dual-action formulation, which combines two distinct pharmacological classes: a mild corticosteroid and a broad-spectrum antibiotic.

This composition allows it to address both the skin inflammation (swelling, itching) and the potential for associated bacterial involvement simultaneously, which may differ from single-ingredient treatments.


Q: Is it possible to develop a dependency on Hyoxyson?

A: Official safety warnings indicate that abrupt discontinuation after prolonged or excessive use is generally not recommended.

This is due to the potential risk of an adrenal insufficiency or a steroid withdrawal reaction related to the corticosteroid component.


Q: Does Hyoxyson interact with pain relievers like ibuprofen or acetaminophen?

A: Official regulatory labels indicate that no interactions with other medicinal products have been established for the intended topical use of Hyoxyson.

While this topical product generally poses no established interaction risk with systemic pain relievers like ibuprofen or acetaminophen, official labeling states no drug-drug interactions have been established for the intended topical use.


Q: Why do official sources list specific warnings about Hyoxyson and driving?

A: Official patient information often states that the topical medicine does not usually affect your ability to drive or operate machinery.

This is because the amount of medication absorbed through the skin into the bloodstream is typically very low when the product is used as directed.


Q: Is Hyoxyson usually taken every day, or just as needed?

A: The medicine is prescribed as a scheduled treatment to be used over a specific course of time, not 'as needed.'

Official administration guidelines define a daily frequency, such as applying the ointment two to four times daily, to maintain a consistent therapeutic presence.


Q: Is it normal to feel a change in appetite after starting Hyoxyson?

A: Changes in appetite are not listed as a common effect of the topical medicine in official side effect profiles.

However, the corticosteroid component is associated with endocrine disturbances, and systemic effects (such as high blood sugar) related to this disturbance can potentially cause increased hunger or thirst.


Q: Can men and women use Hyoxyson for the same conditions?

A: Official indications for use confirm that the medicine is indicated for conditions such as eczema, dermatitis, and allergic skin conditions.

The regulatory approvals for these conditions are not gender-specific, meaning the medicine is indicated for use by both men and women.


Q: What type of medical professional typically manages treatment with Hyoxyson?

A: Hyoxyson is classified as a prescription-only medicine.

Therefore, the diagnosis, initiation, and management of treatment must be overseen by a physician or another qualified prescribing healthcare professional.


Q: What happens if I accidentally take more Hyoxyson than prescribed?

A: Official guidance on overdosage advises discontinuing the medication and informing a healthcare professional immediately.

Management of accidental over-application is typically managed by treating symptoms and instituting supportive measures.


Q: Does Hyoxyson affect blood pressure readings?

A: Safety warnings require cautious use in patients with pre-existing hypertension (high blood pressure).

If the corticosteroid component is systemically absorbed, it may potentially lead to sodium retention and subsequent elevation in blood pressure readings.


Q: How long does Hyoxyson stay in the body after the last dose?

A: Official pharmacokinetic data (how the drug moves through the body) indicates that systemic absorption of the corticosteroid component can vary after topical use.

However, specific published information on the systemic half-life or exact duration in the body for the antibiotic component after dermal application is typically not available.


Q: Does Hyoxyson have any known interaction with alcohol?

A: Official regulatory labels state that no interactions with other medicinal products have been established for the intended topical use.

There are no specific warnings or contraindications documented regarding the concurrent use of alcohol with this topical medication.


Q: How long do most patients take Hyoxyson?

A: Administration guidelines emphasize that the topical ointment should not be continued for more than seven days if clinical improvement has not been observed.

The administration guidelines indicate that the medicine is intended for short-term use, emphasizing the 7-day duration limit.


Q: Are there any major drug classes that Hyoxyson is known to interact with?

A: The official regulatory profile indicates that no interactions with other co-administered medicinal products have been established for the intended topical use of Hyoxyson.

Therefore, there are no specific warnings against major drug classes based on the topical application.


Q: Why do some people report feeling dizzy or lightheaded on Hyoxyson?

A: Dizziness or lightheadedness are not typically listed as common or serious adverse reactions to the topical product in official documents.

However, a related side effect called vertigo (a sensation of spinning or imbalance) has been reported in patients taking the corticosteroid component systemically.


Q: Is Hyoxyson linked to any long-term changes in weight?

A: While not a common effect of the topical drug, the systemic absorption of the corticosteroid component may potentially lead to signs of a Cushingoid state.

This serious side effect, described in official warnings, can include symptoms such as a puffy face or weight gain, but usually only occurs with extensive or prolonged use.


Q: Can Hyoxyson be used by people with a history of heart conditions?

A: Official safety notes advise that patients with pre-existing conditions like congestive heart failure or hypertension (high blood pressure) require cautious use of the medicine.

Official safety notes advise that these conditions require cautious use and that monitoring by a healthcare professional may be needed during treatment.


Q: Does the efficacy of Hyoxyson change over time?

A: Regulatory overviews only provide insight into short-term changes observed in clinical studies for the topical combination.

The official evidence base notes that the long-term effects and stability of any observed patterns of efficacy are not fully established.


Q: What should a patient do if they suspect a rare side effect from Hyoxyson?

A: Official regulatory guidance requires that patients and healthcare professionals report all suspected adverse reactions to the national regulatory body or monitoring scheme in their country.

This process allows the continued safety monitoring of the medicine after it is made available to the public.


Q: Do studies support the use of Hyoxyson across all age ranges for which it is approved?

A: Clinical research has primarily examined adults and children over the age of six for the medicine's use in certain skin conditions.

It is important to note that the topical ointment form is not recommended for use in infants and small children, reflecting an exclusion from the youngest age ranges.


Q: Is Hyoxyson meant to cure a condition, or manage its symptoms?

A: The medicine is officially indicated for managing localized inflammation and associated bacterial involvement.

Its dual action is designed to reduce the visible and perceived symptoms of irritation while inhibiting bacterial proliferation, rather than providing a cure.


Q: Does Hyoxyson interact with caffeine?

A: Official regulatory labels state that no interactions with other medicinal products have been established for the intended topical use.

This absence of established risk includes common substances like caffeine.


Q: Are there any common foods or drinks that interact with Hyoxyson?

A: The official regulatory profile indicates that no drug-food or drug-drink interactions are formally documented for the intended topical use of Hyoxyson.

This means that no mandatory time separation rules are specified for co-administered products, food, or drinks.


Q: Is Hyoxyson approved for use in children?

A: Official guidance states that the topical ointment form is not recommended for use in infants and small children.

Safety notes emphasize the need for careful observation of growth and development in pediatric patients due to the systemic risks of the corticosteroid component.


Q: Can someone take Hyoxyson if they have kidney problems?

A: Official documents specify that no special precautions are required regarding the use of Hyoxyson in populations with renal (kidney) or hepatic (liver) impairment.

Caution is still advised if the patient has pre-existing fluid retention or hypertension.


Q: What is the official safety classification of Hyoxyson in pregnancy?

A: Official labeling advises that topical corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

It is generally recommended that they not be used extensively or for prolonged periods by pregnant individuals.


Q: What is the risk of an allergic reaction to Hyoxyson?

A: Allergic reactions, including contact dermatitis, are noted in official reporting as events that may occur occasionally but are rare.

If an allergic reaction is suspected, official guidance advises that treatment is typically immediately discontinued.

How should Hyoxyson be stored and disposed of?

How to Store and Dispose of Hyoxyson?

Official regulatory documents provide mandatory instructions regarding the storage and disposal of this topical preparation.

️ Storage Requirements

Condition Regulatory Requirement
Temperature Must be stored at or below 25 C (77 F).
Protection Keep in a dry place, protected from direct sunlight and excessive heat.
Packaging Keep the tube tightly closed; do not transfer to another container.
Child Safety Must be kept out of the sight and reach of children.

️ Disposal Rules

Official guidance requires that this medication must not be disposed of via household waste or flushed down wastewater. Instead, any unused or expired Hyoxyson should be returned to a pharmacist or designated collection point for appropriate and environmentally safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hyoxyson found in:

A-Z Index: